Valuation Update With 7 Day Price Move • Jun 15
Investor sentiment improves as stock rises 26% After last week's 26% share price gain to ₹60.53, the stock trades at a trailing P/E ratio of 15.4x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 49% over the past three years. Reported Earnings • May 23
Full year 2026 earnings released: EPS: ₹4.23 (vs ₹3.86 in FY 2025) Full year 2026 results: EPS: ₹4.23 (up from ₹3.86 in FY 2025). Revenue: ₹1.67b (up 30% from FY 2025). Net income: ₹36.8m (up 11% from FY 2025). Profit margin: 2.2% (down from 2.6% in FY 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 97% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth. New Risk • May 21
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 4.8% per year over the past 5 years. Market cap is less than US$10m (₹564.8m market cap, or US$5.86m). Minor Risk High level of debt (44% net debt to equity). Valuation Update With 7 Day Price Move • May 14
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₹48.16, the stock trades at a trailing P/E ratio of 9.7x. Average trailing P/E is 22x in the Chemicals industry in India. Total loss to shareholders of 12% over the past three years. Duyuru • May 13
Ritesh International Limited to Report Q4, 2026 Results on May 21, 2026 Ritesh International Limited announced that they will report Q4, 2026 results on May 21, 2026 New Risk • Mar 23
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 4.8% per year over the past 5 years. Market cap is less than US$10m (₹444.3m market cap, or US$4.75m). Minor Risks High level of debt (44% net debt to equity). Share price has been volatile over the past 3 months (7.7% average weekly change). Valuation Update With 7 Day Price Move • Mar 23
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₹47.40, the stock trades at a trailing P/E ratio of 9.6x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 22% over the past three years. Reported Earnings • Feb 01
Third quarter 2026 earnings released: EPS: ₹1.39 (vs ₹1.06 in 3Q 2025) Third quarter 2026 results: EPS: ₹1.39 (up from ₹1.06 in 3Q 2025). Revenue: ₹444.7m (up 14% from 3Q 2025). Net income: ₹11.9m (up 31% from 3Q 2025). Profit margin: 2.7% (up from 2.3% in 3Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 58% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth. Duyuru • Jan 24
Ritesh International Limited to Report Q3, 2026 Results on Jan 30, 2026 Ritesh International Limited announced that they will report Q3, 2026 results on Jan 30, 2026 Valuation Update With 7 Day Price Move • Jan 05
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to ₹72.89, the stock trades at a trailing P/E ratio of 14.3x. Average trailing P/E is 24x in the Chemicals industry in India. Total returns to shareholders of 1.3% over the past three years. Reported Earnings • Nov 11
Second quarter 2026 earnings released: EPS: ₹1.24 (vs ₹0.28 in 2Q 2025) Second quarter 2026 results: EPS: ₹1.24 (up from ₹0.28 in 2Q 2025). Revenue: ₹387.5m (up 50% from 2Q 2025). Net income: ₹10.6m (up 340% from 2Q 2025). Profit margin: 2.7% (up from 0.9% in 2Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Nov 07
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹64.83, the stock trades at a trailing P/E ratio of 15.7x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 15% over the past three years. Duyuru • Nov 04
Ritesh International Limited to Report Q2, 2026 Results on Nov 10, 2025 Ritesh International Limited announced that they will report Q2, 2026 results on Nov 10, 2025 Duyuru • Oct 03
Ritesh International Limited announced that it expects to receive INR 37.9086 million in funding Ritesh International Limited announces a private placement with Ritesh Arora and Rijul Arora to issue 820,000 Equity Shares at a price of INR 46.23 per share for gross proceeds of INR 37,908,600 on October 1, 2025. Valuation Update With 7 Day Price Move • Sep 24
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to ₹48.13, the stock trades at a trailing P/E ratio of 11.7x. Average trailing P/E is 27x in the Chemicals industry in India. Total loss to shareholders of 45% over the past three years. Valuation Update With 7 Day Price Move • Sep 02
Investor sentiment improves as stock rises 23% After last week's 23% share price gain to ₹32.69, the stock trades at a trailing P/E ratio of 7.9x. Average trailing P/E is 27x in the Chemicals industry in India. Total loss to shareholders of 64% over the past three years. Duyuru • Aug 25
Ritesh International Limited, Annual General Meeting, Sep 19, 2025 Ritesh International Limited, Annual General Meeting, Sep 19, 2025, at 11:00 Indian Standard Time. Location: momnabad road, village akbarpura, ahmedgarh, sangrur, punjab 148021, sangrur India Valuation Update With 7 Day Price Move • Aug 14
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to ₹28.60, the stock trades at a trailing P/E ratio of 6.9x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 55% over the past three years. Reported Earnings • Aug 08
First quarter 2026 earnings released: EPS: ₹0.44 (vs ₹0.17 in 1Q 2025) First quarter 2026 results: EPS: ₹0.44 (up from ₹0.17 in 1Q 2025). Revenue: ₹350.5m (up 33% from 1Q 2025). Net income: ₹3.76m (up 162% from 1Q 2025). Profit margin: 1.1% (up from 0.5% in 1Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has only fallen by 19% per year, which means it has not declined as severely as earnings. Duyuru • Aug 02
Ritesh International Limited to Report Q1, 2026 Results on Aug 07, 2025 Ritesh International Limited announced that they will report Q1, 2026 results on Aug 07, 2025 Valuation Update With 7 Day Price Move • May 28
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to ₹42.78, the stock trades at a trailing P/E ratio of 11.1x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 1.5% over the past three years. Reported Earnings • May 22
Full year 2025 earnings released: EPS: ₹3.86 (vs ₹0.093 loss in FY 2024) Full year 2025 results: EPS: ₹3.86 (up from ₹0.093 loss in FY 2024). Revenue: ₹1.29b (up 54% from FY 2024). Net income: ₹33.0m (up ₹33.8m from FY 2024). Profit margin: 2.6% (up from net loss in FY 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings. Duyuru • May 14
Ritesh International Limited to Report Q4, 2025 Results on May 21, 2025 Ritesh International Limited announced that they will report Q4, 2025 results on May 21, 2025 New Risk • May 05
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₹291.6m market cap, or US$3.46m). Minor Risk Share price has been volatile over the past 3 months (8.6% average weekly change). Valuation Update With 7 Day Price Move • Apr 16
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to ₹34.95, the stock trades at a trailing P/E ratio of 23.5x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 1.3% over the past three years. Reported Earnings • Feb 14
Third quarter 2025 earnings released: EPS: ₹1.06 (vs ₹0.07 in 3Q 2024) Third quarter 2025 results: EPS: ₹1.06 (up from ₹0.07 in 3Q 2024). Revenue: ₹391.6m (up 124% from 3Q 2024). Net income: ₹9.08m (up ₹8.46m from 3Q 2024). Profit margin: 2.3% (up from 0.4% in 3Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 73 percentage points per year, which is a significant difference in performance. Duyuru • Feb 06
Ritesh International Limited to Report Nine Months, 2025 Results on Feb 13, 2025 Ritesh International Limited announced that they will report nine months, 2025 results on Feb 13, 2025 Valuation Update With 7 Day Price Move • Nov 12
Investor sentiment improves as stock rises 28% After last week's 28% share price gain to ₹32.19, the stock trades at a trailing P/E ratio of 64.8x. Average trailing P/E is 34x in the Chemicals industry in India. Total returns to shareholders of 6.9% over the past three years. Reported Earnings • Nov 06
Second quarter 2025 earnings released: EPS: ₹0.28 (vs ₹0.01 in 2Q 2024) Second quarter 2025 results: EPS: ₹0.28 (up from ₹0.01 in 2Q 2024). Revenue: ₹259.1m (up 28% from 2Q 2024). Net income: ₹2.41m (up ₹2.33m from 2Q 2024). Profit margin: 0.9% (up from 0% in 2Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 72 percentage points per year, which is a significant difference in performance. Duyuru • Oct 26
Ritesh International Limited to Report Q2, 2025 Results on Nov 05, 2024 Ritesh International Limited announced that they will report Q2, 2025 results on Nov 05, 2024 Duyuru • Aug 26
Ritesh International Limited, Annual General Meeting, Sep 21, 2024 Ritesh International Limited, Annual General Meeting, Sep 21, 2024, at 11:00 Indian Standard Time. Location: momnabad road, village akbarpura, ahmedgarh, sangrur, punjab 148021, sangrur India Reported Earnings • Aug 10
First quarter 2025 earnings released: EPS: ₹0.17 (vs ₹0.15 loss in 1Q 2024) First quarter 2025 results: EPS: ₹0.17 (up from ₹0.15 loss in 1Q 2024). Revenue: ₹264.1m (up 24% from 1Q 2024). Net income: ₹1.43m (up ₹2.72m from 1Q 2024). Profit margin: 0.5% (up from net loss in 1Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 68 percentage points per year, which is a significant difference in performance. Duyuru • Aug 02
Ritesh International Limited to Report Q1, 2025 Results on Aug 09, 2024 Ritesh International Limited announced that they will report Q1, 2025 results on Aug 09, 2024 Duyuru • May 25
Ritesh International Limited to Report Q4, 2024 Results on May 30, 2024 Ritesh International Limited announced that they will report Q4, 2024 results on May 30, 2024 Board Change • May 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 1 highly experienced director. Non-Executive Independent Director Komal Bhalla was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Feb 15
Third quarter 2024 earnings released: EPS: ₹0.07 (vs ₹0.098 in 3Q 2023) Third quarter 2024 results: EPS: ₹0.07 (down from ₹0.098 in 3Q 2023). Revenue: ₹175.1m (down 29% from 3Q 2023). Net income: ₹620.0k (down 26% from 3Q 2023). Profit margin: 0.4% (up from 0.3% in 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has increased by 20% per year, which means it is well ahead of earnings. Duyuru • Feb 07
Ritesh International Limited to Report Q3, 2024 Results on Feb 13, 2024 Ritesh International Limited announced that they will report Q3, 2024 results on Feb 13, 2024 Recent Insider Transactions • Nov 10
Non-Executive Director recently sold ₹478k worth of stock On the 9th of November, Ritesh Arora sold around 16k shares on-market at roughly ₹30.79 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of ₹2.0m more than they bought in the last 12 months. Reported Earnings • Oct 29
Second quarter 2024 earnings released: EPS: ₹0.01 (vs ₹0.59 in 2Q 2023) Second quarter 2024 results: EPS: ₹0.01 (down from ₹0.59 in 2Q 2023). Revenue: ₹203.1m (down 37% from 2Q 2023). Net income: ₹83.0k (down 98% from 2Q 2023). Profit margin: 0% (down from 1.6% in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has increased by 40% per year, which means it is well ahead of earnings. Duyuru • Oct 19
Ritesh International Limited to Report Q2, 2024 Results on Oct 26, 2023 Ritesh International Limited announced that they will report Q2, 2024 results on Oct 26, 2023 Buying Opportunity • Sep 07
Now 20% undervalued after recent price drop Over the last 90 days, the stock is down 6.5%. The fair value is estimated to be ₹47.24, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 31% over the last 3 years. Meanwhile, the company became loss making. Duyuru • Aug 26
Ritesh International Limited, Annual General Meeting, Sep 26, 2023 Ritesh International Limited, Annual General Meeting, Sep 26, 2023, at 11:00 Indian Standard Time. Location: Momnabad Road, Village Akbarpura, (Ahmedgarh) Sangrur Punjab India Agenda: To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended on March 31, 2023 including Audited Balance Sheet as at March 31, 2023, the Statement of Profit & Loss and Cash Flow Statement for the year ended on that date along with the Reports of the Auditors and Directors thereon; to consider and approve, with or without modification, the appointment of Mr. Rijul Arora, who retires by rotation and being eligible, offers himself for reappointment; and to discuss other business matters. Reported Earnings • Aug 16
First quarter 2024 earnings released: ₹0.15 loss per share (vs ₹1.99 profit in 1Q 2023) First quarter 2024 results: ₹0.15 loss per share (down from ₹1.99 profit in 1Q 2023). Revenue: ₹212.5m (down 57% from 1Q 2023). Net loss: ₹1.29m (down 108% from profit in 1Q 2023). Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has increased by 65% per year, which means it is tracking significantly ahead of earnings growth. Duyuru • Aug 08
Ritesh International Limited to Report Q1, 2024 Results on Aug 14, 2023 Ritesh International Limited announced that they will report Q1, 2024 results on Aug 14, 2023 Recent Insider Transactions • Jun 02
Additional Non-Executive Director recently sold ₹386k worth of stock On the 1st of June, Ritesh Arora sold around 9k shares on-market at roughly ₹44.48 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger sale worth ₹727k. Insiders have been net sellers, collectively disposing of ₹1.5m more than they bought in the last 12 months. Valuation Update With 7 Day Price Move • Jun 01
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₹44.36, the stock trades at a trailing P/E ratio of 36x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 1,265% over the past three years. Reported Earnings • May 27
Full year 2023 earnings released: EPS: ₹1.23 (vs ₹4.17 in FY 2022) Full year 2023 results: EPS: ₹1.23 (down from ₹4.17 in FY 2022). Revenue: ₹1.27b (down 9.8% from FY 2022). Net income: ₹10.5m (down 71% from FY 2022). Profit margin: 0.8% (down from 2.5% in FY 2022). Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has increased by 153% per year, which means it is tracking significantly ahead of earnings growth. Duyuru • May 19
Ritesh International Limited to Report Q4, 2023 Results on May 25, 2023 Ritesh International Limited announced that they will report Q4, 2023 results on May 25, 2023 Valuation Update With 7 Day Price Move • Apr 27
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹55.39, the stock trades at a trailing P/E ratio of 10.6x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 1,285% over the past three years. Valuation Update With 7 Day Price Move • Apr 05
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹42.21, the stock trades at a trailing P/E ratio of 8.1x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 560% over the past three years. Recent Insider Transactions • Mar 08
Additional Non-Executive Director recently sold ₹727k worth of stock On the 6th of March, Ritesh Arora sold around 17k shares on-market at roughly ₹41.57 per share. This transaction amounted to 1.4% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months. Valuation Update With 7 Day Price Move • Feb 28
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹49.40, the stock trades at a trailing P/E ratio of 9.5x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 648% over the past three years. Valuation Update With 7 Day Price Move • Feb 09
Investor sentiment deteriorates as stock falls 22% After last week's 22% share price decline to ₹54.00, the stock trades at a trailing P/E ratio of 10.4x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 744% over the past three years. Reported Earnings • Feb 05
Third quarter 2023 earnings released: EPS: ₹0.098 (vs ₹0.73 in 3Q 2022) Third quarter 2023 results: EPS: ₹0.098 (down from ₹0.73 in 3Q 2022). Revenue: ₹246.0m (down 32% from 3Q 2022). Net income: ₹840.0k (down 87% from 3Q 2022). Profit margin: 0.3% (down from 1.7% in 3Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 63% per year but the company’s share price has increased by 112% per year, which means it is tracking significantly ahead of earnings growth. Duyuru • Jan 26
Ritesh International Ltd to Report Q3, 2023 Results on Feb 02, 2023 Ritesh International Ltd announced that they will report Q3, 2023 results at 3:30 PM, Indian Standard Time on Feb 02, 2023 Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Non-Executive Independent Director Komal Bhalla was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Nov 11
Investor sentiment deteriorated over the past week After last week's 18% share price decline to ₹76.45, the stock trades at a trailing P/E ratio of 13.1x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 1,811% over the past three years. Reported Earnings • Nov 06
Second quarter 2023 earnings released Second quarter 2023 results: Revenue: ₹322.9m (down 7.4% from 2Q 2022). Net income: ₹5.06m (up 5.0% from 2Q 2022). Profit margin: 1.6% (up from 1.4% in 2Q 2022). The increase in margin was driven by lower expenses. Duyuru • Oct 29
Ritesh International Ltd to Report Q2, 2023 Results on Nov 04, 2022 Ritesh International Ltd announced that they will report Q2, 2023 results on Nov 04, 2022 Valuation Update With 7 Day Price Move • Sep 28
Investor sentiment deteriorated over the past week After last week's 22% share price decline to ₹87.75, the stock trades at a trailing P/E ratio of 15.1x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 1,387% over the past three years. Valuation Update With 7 Day Price Move • Sep 13
Investor sentiment improved over the past week After last week's 15% share price gain to ₹104, the stock trades at a trailing P/E ratio of 17.9x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 1,496% over the past three years. Valuation Update With 7 Day Price Move • Aug 25
Investor sentiment improved over the past week After last week's 20% share price gain to ₹75.75, the stock trades at a trailing P/E ratio of 13x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 1,126% over the past three years. Duyuru • Aug 13
Ritesh International Ltd, Annual General Meeting, Sep 16, 2022 Ritesh International Ltd, Annual General Meeting, Sep 16, 2022, at 11:00 Indian Standard Time. Location: Momnabad Road, Village Akbarpura, (Ahmedgarh) District Sangrur, Punjab -148021 Ahmednagar India Agenda: To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended on March 31, 2022 including Audited Balance Sheet as at March 31, 2022, the Statement of Profit & Loss and Cash Flow Statement for the year ended on that date along with the Reports of the Auditors and Directors thereon; to consider the appointment of Mr. Rajiv Arora, who retires by rotation and being eligible, offers himself for reappointment; to ratify the remuneration payable to the Cost Auditor (Verma Khushwinder & Co.) for the FY 2022-23; and to consider other matters. Duyuru • Aug 06
Ritesh International Ltd to Report Q1, 2023 Results on Aug 12, 2022 Ritesh International Ltd announced that they will report Q1, 2023 results at 3:30 PM, Indian Standard Time on Aug 12, 2022 Valuation Update With 7 Day Price Move • Jul 26
Investor sentiment improved over the past week After last week's 15% share price gain to ₹53.75, the stock trades at a trailing P/E ratio of 12.9x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 1,180% over the past three years. Valuation Update With 7 Day Price Move • Jun 14
Investor sentiment improved over the past week After last week's 19% share price gain to ₹50.80, the stock trades at a trailing P/E ratio of 12.2x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 719% over the past three years. Valuation Update With 7 Day Price Move • May 19
Investor sentiment improved over the past week After last week's 18% share price gain to ₹36.10, the stock trades at a trailing P/E ratio of 18.3x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 688% over the past three years. Buying Opportunity • May 11
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 7.2%. The fair value is estimated to be ₹40.94, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 43% over the last 3 years. Meanwhile, the company has become profitable. Duyuru • May 10
Ritesh International Ltd to Report Q4, 2022 Results on May 18, 2022 Ritesh International Ltd announced that they will report Q4, 2022 results on May 18, 2022 Board Change • Apr 27
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Non-Executive Independent Director Komal Bhalla was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Mar 08
Investor sentiment improved over the past week After last week's 15% share price gain to ₹31.85, the stock trades at a trailing P/E ratio of 16.1x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 314% over the past three years. Buying Opportunity • Feb 23
Now 20% undervalued The stock has been flat over the last 90 days. The fair value is estimated to be ₹37.03, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 43% per annum over the last 3 years. The company has become profitable over the last 3 years. Board Change • Feb 17
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Non-Executive Independent Director Komal Bhalla was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Jan 03
Investor sentiment improved over the past week After last week's 20% share price gain to ₹38.15, the stock trades at a trailing P/E ratio of 10.3x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 570% over the past three years. Reported Earnings • Nov 01
Second quarter 2022 earnings released: EPS ₹0.56 (vs ₹0.45 in 2Q 2021) The company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2022 results: Revenue: ₹348.5m (up 93% from 2Q 2021). Net income: ₹4.82m (up 26% from 2Q 2021). Profit margin: 1.4% (down from 2.1% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 98% per year but the company’s share price has only increased by 48% per year, which means it is significantly lagging earnings growth. Board Change • Sep 03
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Additional Non-Executive Independent Director Kajal Rai was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Jul 01
Full year 2021 earnings released: EPS ₹2.38 (vs ₹0.36 in FY 2020) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: ₹748.8m (up 72% from FY 2020). Net income: ₹20.3m (up ₹17.2m from FY 2020). Profit margin: 2.7% (up from 0.7% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 84% per year but the company’s share price has only increased by 43% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Jun 18
Investor sentiment deteriorated over the past week After last week's 22% share price decline to ₹46.05, the stock trades at a trailing P/E ratio of 13.7x. Average trailing P/E is 22x in the Chemicals industry in India. Total returns to shareholders of 208% over the past three years. Valuation Update With 7 Day Price Move • May 27
Investor sentiment improved over the past week After last week's 16% share price gain to ₹43.05, the stock trades at a trailing P/E ratio of 12.8x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 121% over the past three years. Valuation Update With 7 Day Price Move • May 04
Investor sentiment improved over the past week After last week's 16% share price gain to ₹37.05, the stock trades at a trailing P/E ratio of 11.1x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 173% over the past three years. Valuation Update With 7 Day Price Move • Apr 08
Investor sentiment improved over the past week After last week's 27% share price gain to ₹28.65, the stock trades at a trailing P/E ratio of 8.5x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 160% over the past three years. Is New 90 Day High Low • Feb 15
New 90-day high: ₹14.68 The company is up 13% from its price of ₹13.00 on 17 November 2020. The Indian market is up 21% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 16% over the same period. Reported Earnings • Feb 12
Third quarter 2021 earnings released: EPS ₹2.48 (vs ₹1.07 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₹247.6m (up 102% from 3Q 2020). Net income: ₹21.2m (up 132% from 3Q 2020). Profit margin: 8.6% (up from 7.5% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 67% per year but the company’s share price has only increased by 42% per year, which means it is significantly lagging earnings growth. Duyuru • Feb 03
Ritesh International Ltd to Report Q3, 2021 Results on Feb 10, 2021 Ritesh International Ltd announced that they will report Q3, 2021 results on Feb 10, 2021 Duyuru • Dec 13
Ritesh International Ltd Announces Appointment of Ritesh Arora as an Additional Director Ritesh International Ltd. announced that Mr. Ritesh Arora has been appointed by the board as an Additional Director of the company with effect from December 12, 2020. Valuation Update With 7 Day Price Move • Oct 22
Market pulls back on stock over the past week After last week's 16% share price decline to ₹11.40, the stock is trading at a trailing P/E ratio of 12.6x, down from the previous P/E ratio of 14.9x. This compares to an average P/E of 15x in the Chemicals industry in India. Total returns to shareholders over the past three years are 171%. Valuation Update With 7 Day Price Move • Oct 17
Market pulls back on stock over the past week After last week's 17% share price decline to ₹12.86, the stock is trading at a trailing P/E ratio of 14.2x, down from the previous P/E ratio of 17.1x. This compares to an average P/E of 15x in the Chemicals industry in India. Total returns to shareholders over the past three years are 199%. Duyuru • Oct 13
Ritesh International Ltd Announces Retirement of Reeta Challana as an Independent Director Ritesh International Ltd. announced that at the Annual General Meeting held on September 28, 2020, the shareholders rejected the the resolution of re-appointment of Mrs. Reeta Challana as an independent Director. Duyuru • Oct 02
Ritesh International Ltd Appoints Kajal Rai as Additional Director (Independent Director) Ritesh International Ltd. announced that Ms. Kajal Rai has been appointed by the board as an Additional Director (Independent Director of the company with effect from October 1, 2020. Is New 90 Day High Low • Sep 30
New 90-day high: ₹13.20 The company is up 269% from its price of ₹3.58 on 01 July 2020. The Indian market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 15% over the same period. Duyuru • Aug 09
Ritesh International Ltd to Report Q1, 2021 Results on Aug 14, 2020 Ritesh International Ltd announced that they will report Q1, 2021 results on Aug 14, 2020 Duyuru • Jun 20
Ritesh International Ltd to Report Q4, 2020 Results on Jun 26, 2020 Ritesh International Ltd announced that they will report Q4, 2020 results on Jun 26, 2020 
